Sale!

Next Generation Sequencing for Bethlem Myopathy, Myofibrillar Myopathy, and Ullrich Muscular Dystrophy Test

Original price was: $650.Current price is: $586.

-10%

The Next Generation Sequencing test for Bethlem Myopathy, Myofibrillar Myopathy, and Ullrich Muscular Dystrophy is a comprehensive genetic analysis that identifies mutations in key genes associated with these rare muscular disorders. This advanced diagnostic tool utilizes cutting-edge sequencing technology to detect abnormalities in genes including BAG3, COL6A1, COL6A2, COL6A3, CRYAB, DES, FLNC, LDB3, and MYOT. The test is essential for patients experiencing progressive muscle weakness, joint contractures, and mobility issues. With results available in 40 working days and a discounted price of $586 USD, this test provides crucial information for accurate diagnosis and personalized treatment planning. Early detection through this comprehensive genetic screening can significantly improve patient outcomes and quality of life.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

Next Generation Sequencing for Bethlem Myopathy, Myofibrillar Myopathy, and Ullrich Muscular Dystrophy Test

Comprehensive Genetic Analysis for Muscular Disorders

The Next Generation Sequencing test for Bethlem Myopathy, Myofibrillar Myopathy, and Ullrich Muscular Dystrophy represents a breakthrough in genetic diagnostics for rare muscular conditions. This sophisticated testing methodology employs advanced sequencing technologies to provide comprehensive analysis of multiple genes simultaneously, offering unprecedented accuracy in identifying the genetic basis of these complex neuromuscular disorders.

What This Test Measures and Detects

This comprehensive genetic panel specifically targets and analyzes nine critical genes associated with muscular dystrophy and myopathy conditions:

  • BAG3 Gene: Associated with myofibrillar myopathy and cardiomyopathy
  • COL6A1, COL6A2, COL6A3 Genes: Critical for collagen VI production, linked to Bethlem and Ullrich muscular dystrophies
  • CRYAB Gene: Involved in alpha-B-crystallin protein, related to myofibrillar myopathy
  • DES Gene: Encodes desmin protein, crucial for muscle structure
  • FLNC Gene: Filamin C gene mutations associated with myofibrillar myopathy
  • LDB3 Gene: ZASP protein encoding gene linked to muscular disorders
  • MYOT Gene: Myotilin gene mutations causing myofibrillar myopathy

Who Should Consider This Genetic Test

This advanced genetic screening is recommended for individuals presenting with:

  • Progressive muscle weakness beginning in childhood or adulthood
  • Joint contractures affecting mobility and flexibility
  • Family history of muscular dystrophy or myopathy conditions
  • Unexplained muscle stiffness or rigidity
  • Difficulty with motor skills and physical activities
  • Muscle biopsy findings suggestive of myofibrillar pathology
  • Cardiac involvement alongside muscular symptoms
  • Respiratory complications related to muscle weakness

Clinical Benefits of Genetic Testing

Undergoing this comprehensive genetic analysis provides numerous advantages:

  • Accurate Diagnosis: Precise identification of the specific genetic mutation responsible for symptoms
  • Personalized Treatment Planning: Tailored therapeutic approaches based on genetic findings
  • Family Planning Guidance: Understanding inheritance patterns for future generations
  • Prognostic Information: Insight into disease progression and potential complications
  • Early Intervention Opportunities: Timely management strategies to preserve muscle function
  • Elimination of Diagnostic Uncertainty: Resolution of ambiguous clinical presentations

Understanding Your Test Results

Our comprehensive genetic analysis provides detailed insights into your muscular health:

  • Positive Result: Identifies specific genetic mutations, confirming diagnosis and guiding treatment
  • Negative Result: Rules out common genetic causes, directing further diagnostic evaluation
  • Variant of Uncertain Significance: Identifies genetic changes requiring additional clinical correlation
  • Carrier Status: Determines risk of passing conditions to offspring

All results are accompanied by detailed interpretation from our board-certified genetic specialists, ensuring you receive comprehensive guidance and next-step recommendations.

Test Pricing and Details

Test Component Details
Test Name Next Generation Sequencing for Bethlem Myopathy, Myofibrillar Myopathy, and Ullrich Muscular Dystrophy
Regular Price $650 USD
Discount Price $586 USD
Turnaround Time 40 Working Days
Sample Type 10 mL whole blood from 2 Lavender Top (EDTA) tubes
Testing Method Next Generation Sequencing with Sanger Sequencing confirmation

Nationwide Testing Availability

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York City, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network of certified collection centers ensures accessible genetic testing services nationwide.

Take Control of Your Muscular Health Today

Don’t let uncertainty about your muscular symptoms delay proper diagnosis and treatment. Our advanced genetic testing provides the clarity needed to make informed healthcare decisions. With our discounted pricing and comprehensive analysis, you can access world-class genetic diagnostics without financial burden.

Ready to begin your diagnostic journey? Contact our genetic specialists today at +1(267) 388-9828 or schedule your appointment online. Our team is available to answer your questions and guide you through the testing process with compassion and expertise.

Early genetic diagnosis can significantly impact treatment outcomes and quality of life. Take the first step toward understanding your muscular health with our comprehensive Next Generation Sequencing test.